Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,002 public trials 2,553 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

NCT07419295

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Munson Medical Center ( Site 0812) Traverse City, Michigan, United States
  • TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822) Cincinnati, Ohio, United States
  • The West Clinic, P.C. ( Site 0791) Germantown, Tennessee, United States
  • Thompson Cancer Survival Center ( Site 0803) Knoxville, Tennessee, United States
View all 94 locations
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

NCT06863272

Conditions
Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +14 more
Locations
  • UCLA Hematology & Oncology ( Site 0003) Los Angeles, California, United States
  • University of California-Irvine Medical Center ( Site 0016) Orange, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0034) San Francisco, California, United States
  • MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) Washington D.C., District of Columbia, United States
View all 82 locations
View Trial Details
Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

NCT07489495

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102) Marietta, Georgia, United States
  • The West Clinic, P.C. ( Site 0115) Germantown, Tennessee, United States
  • Centro Oncologico Korben ( Site 0254) CABA, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires ( Site 0253) Ciudad de Buenos Aires, Buenos Aires, Argentina
View all 90 locations
View Trial Details
Recruiting

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

NCT06353386

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • UCSD Moores Cancer Center ( Site 0039) La Jolla, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center-Cancer Research Services ( Site 0051) Miami, Florida, United States
  • University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0049) Baltimore, Maryland, United States
View all 77 locations
View Trial Details
Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

NCT06952504

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 6033) Mobile, Alabama, United States
  • Alaska Women's Cancer Care ( Site 6036) Anchorage, Alaska, United States
  • CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014) Irvine, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020) Orange, California, United States
View all 264 locations
View Trial Details

Related conditions